The company saw its DNA data as an engine that would revolutionize drug discovery and medical care, but it never found a ...
A breakthrough in safely delivering therapeutic DNA to cells could transform treatment for millions suffering from common ...
DNA genetics testing company 23andMe has filed for Chapter 11 bankruptcy. It emphasizes there will be uninterrupted service ...
A bankruptcy filing by personalized genomics firm 23andMe (ME) calls into question what happens to its most valuable asset: ...
A warning has been sent to 15 million people who are at risk of having their DNA information sold as 23andme filed for ...
Over the weekend, biotechnology company 23andMe filed for Chapter 11 bankruptcy. Questions remain over what could happen to ...
The genetic testing company holds biological information on millions of people.
A breakthrough in safely delivering therapeutic DNA to cells could transform treatment for millions suffering from common chronic diseases like heart disease, diabetes, and cancer.
Me recently filed for bankruptcy. Here's how users can download and delete their data from the platform ahead of the sale.
Genetic testing company 23andMe said it has begun bankruptcy proceedings, seeking to maximize value through a ...
Me recently filed for bankruptcy. Here's how users can download and delete their data from the platform ahead of the sale.
MAIA Biotechnology, Inc., (NYSE American: MAIA) ("MAIA", the "Company"), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today announced that an abstract ...